MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer

We performed a high-throughput retroviral insertional mutagenesis screen in mouse mammary tumor virus (MMTV)-induced mammary tumors and identified 33 common insertion sites, of which 17 genes were previously not known to be associated with mammary cancer and 13 had not previously been linked to cancer in general. Although members of the Wnt and fibroblast growth factors (Fgf) families were frequently tagged, our exhaustive screening for MMTV insertion sites uncovered a new repertoire of candidate breast cancer oncogenes. We validated one of these genes, Rspo3, as an oncogene by overexpression in a p53-deficient mammary epithelial cell line. The human orthologs of the candidate oncogenes were frequently deregulated in human breast cancers and associated with several tumor parameters. Computational analysis of all MMTV-tagged genes uncovered specific gene families not previously associated with cancer and showed a significant overrepresentation of protein domains and signaling pathways mainly associated with development and growth factor signaling. Comparison of all tagged genes in MMTV and Moloney murine leukemia virus–induced malignancies showed that both viruses target mostly different genes that act predominantly in distinct pathways.

[1]  B. Groner,et al.  Genomic location of mouse mammary tumor virus proviral DNA in normal mouse tissue and in mammary tumors. , 1980, Cold Spring Harbor symposia on quantitative biology.

[2]  H. Varmus,et al.  Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. S. Lee,et al.  Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Anton Berns,et al.  High-throughput retroviral tagging to identify components of specific signaling pathways in cancer , 2002, Nature Genetics.

[5]  C. Niehrs,et al.  R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. , 2004, Developmental cell.

[6]  B. Weigelt,et al.  Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas , 2004, Oncogene.

[7]  Y-j Liu,et al.  Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively , 2006, Oncogene.

[8]  R. Cardiff,et al.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. , 2002, The American journal of pathology.

[9]  H. Varmus,et al.  Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice , 1992, Molecular and cellular biology.

[10]  K. Ying,et al.  Cloning and identification of a cDNA that encodes a novel human protein with thrombospondin type I repeat domain, hPWTSR , 2002, Molecular Biology Reports.

[11]  A. Berns,et al.  Retroviral insertional mutagenesis as a strategy to identify cancer genes. , 1996, Biochimica et biophysica acta.

[12]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[13]  Harold E. Varmus,et al.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.

[14]  D. Gallahan,et al.  Mammary tumorigenesis in feral mice: identification of a new int locus in mouse mammary tumor virus (Czech II)-induced mammary tumors , 1987, Journal of virology.

[15]  R. Callahan,et al.  MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways , 2000, Oncogene.

[16]  T. Ogura,et al.  Tbx5 and Tbx4 trigger limb initiation through activation of the Wnt/Fgf signaling cascade , 2003, Development.

[17]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[18]  G. Dontu,et al.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.

[19]  G. Sourvinos,et al.  Overexpression of the Tpl-2/Cot oncogene in human breast cancer , 1999, Oncogene.

[20]  R. Callahan,et al.  A New Common Integration Site, Int7, for the Mouse Mammary Tumor Virus in Mouse Mammary Tumors Identifies a Gene Whose Product Has Furin-Like and Thrombospondin-Like Sequences , 2005, Journal of Virology.

[21]  P. Pavlidis.  Using ANOVA for gene selection from microarray studies of the nervous system. , 2003, Methods.

[22]  Takeshi Oshima,et al.  Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium , 2005, Science.

[23]  F. Bertucci,et al.  Expression of fgf and fgf receptor genes in human breast cancer , 1995, International journal of cancer.

[24]  G. Peters,et al.  Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms. , 1992, Oncogene.

[25]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[26]  D. Largaespada,et al.  Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system , 2005, Nature.

[27]  A. Feinberg,et al.  Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice , 2005, Science.

[28]  S. Yamanaka,et al.  Role of ERas in promoting tumour-like properties in mouse embryonic stem cells , 2003, Nature.

[29]  Douglas R Lowy,et al.  p16INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB , 2003, Oncogene.

[30]  Marc Payton,et al.  Deregulation of Cyclin E2 expression and associated kinase activity in primary breast tumors , 2002, Oncogene.

[31]  D. Taverna,et al.  Growth suppression of normal mammary epithelial cells by wild-type p53. , 1994, Oncogene.

[32]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[33]  G. Peters,et al.  Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus , 1986, Nature.

[34]  J. Peli,et al.  Involvement of the Tpl-2/cot oncogene in MMTV tumorigenesis. , 1996, Oncogene.

[35]  D J Porteous,et al.  Splinkerettes--improved vectorettes for greater efficiency in PCR walking. , 1995, Nucleic acids research.

[36]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[37]  T. Hughes,et al.  Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. , 2000, Science.

[38]  Carl-Fredrik Tiger,et al.  Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Hatten,et al.  Mice that lack astrotactin have slowed neuronal migration. , 2002, Development.

[40]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[41]  J. Foekens,et al.  Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures , 1998, FEBS letters.

[42]  David J. Sheskin,et al.  Handbook of Parametric and Nonparametric Statistical Procedures , 1997 .

[43]  D. Gallahan,et al.  The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4) , 1997, Oncogene.

[44]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[45]  G. Boivin,et al.  Haploinsufficiency of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump, predisposes mice to squamous cell tumors via a novel mode of cancer susceptibility. , 2005, Cancer research.

[46]  B. Rudy,et al.  DPP10 Modulates Kv4-mediated A-type Potassium Channels* , 2005, Journal of Biological Chemistry.

[47]  N. Copeland,et al.  Tpl-2 is an oncogenic kinase that is activated by carboxy-terminal truncation. , 1997, Genes & development.